Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Ciou S.-C.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 3 到 8 筆資料,總共 8 筆
< 上一頁
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2008
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
JEN-CHUNG KO
; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
Carcinogenesis
55
54
2009
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
JEN-CHUNG KO
; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
Lung Cancer
9
9
2008
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
JEN-CHUNG KO
; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
Molecular Cancer Therapeutics
38
35
2009
Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells
JEN-CHUNG KO
; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
Molecular Cancer Research
45
40
2010
Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells
JEN-CHUNG KO
; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
Biochemical Pharmacology
71
62
2015
Zebrafish as a disease model for studying human hepatocellular carcinoma
Lu J.-W.; Ho Y.-J.; Yang Y.-J.; Liao H.-A.; Ciou S.-C.; LIANG-IN LIN
; DA-LIANG OU
World Journal of Gastroenterology
49
38